NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at …

COSTA MESA, CA., March 07, 2018 (GLOBE NEWSWIRE) — NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced today that Dr. Brian Murphy, CEO and Chief Medical Officer, will participate at the 2018 Sachs BioCapital USA Forum at the New York Academy of Sciences, on March 21, 2018 in New York City. The Academy, founded in 1817, fosters scientific excellence globally and counts thirty-six Nobel laureates among its President’s Council. Dr. Murphy, a member of the New

...read more at https://globenewswire.com/news-release/2018/03/07/1417584/0/en/NEMUS-Bioscience-to-Participate-in-Sachs-BioCapital-USA-Forum-at-the-New-York-Academy-of-Sciences.html